Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Globus Medical Inc (NYSE: GMED) closed at $69.86 up 1.56% from its previous closing price of $68.79. In other words, the price has increased by $1.56 from its previous closing price. On the day, 0.83 million shares were traded. GMED stock price reached its highest trading level at $70.32 during the session, while it also had its lowest trading level at $68.6.
Ratios:
For a deeper understanding of Globus Medical Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 19.19 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 58.75. For the most recent quarter (mrq), Quick Ratio is recorded 1.45 and its Current Ratio is at 2.42. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on August 07, 2024, Upgraded its rating to Overweight and sets its target price to $78 from $60 previously.
On May 20, 2024, Piper Sandler Upgraded its rating to Overweight which previously was Neutral and also upped its target price recommendation from $60 to $80.
BTIG Research Upgraded its Neutral to Buy on March 18, 2024, while the target price for the stock was maintained at $60.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jul 11 ’24 when Norwalk Leslie V sold 1,000 shares for $70.00 per share. The transaction valued at 70,000 led to the insider holds 16,419 shares of the business.
Lemaitre Dan sold 63,300 shares of GMED for $4,090,022 on May 10 ’24. The Director now owns 0 shares after completing the transaction at $64.61 per share. On May 08 ’24, another insider, Davidar David D, who serves as the Director of the company, sold 20,000 shares for $65.00 each. As a result, the insider received 1,300,000 and left with 566,275 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GMED now has a Market Capitalization of 9459533824 and an Enterprise Value of 9497628672. As of this moment, Globus’s Price-to-Earnings (P/E) ratio for their current fiscal year is 235.93, and their Forward P/E ratio for the next fiscal year is 21.00. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 14.21. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.23 while its Price-to-Book (P/B) ratio in mrq is 2.38. Its current Enterprise Value per Revenue stands at 4.247 whereas that against EBITDA is 16.379.
Stock Price History:
Over the past 52 weeks, GMED has reached a high of $74.21, while it has fallen to a 52-week low of $43.38. The 50-Day Moving Average of the stock is 0.79%, while the 200-Day Moving Average is calculated to be 22.37%.
Shares Statistics:
For the past three months, GMED has traded an average of 993.47K shares per day and 1606190 over the past ten days. A total of 113.91M shares are outstanding, with a floating share count of 112.00M. Insiders hold about 17.20% of the company’s shares, while institutions hold 87.54% stake in the company. Shares short for GMED as of 1722384000 were 4833541 with a Short Ratio of 4.87, compared to 1719532800 on 7160196. Therefore, it implies a Short% of Shares Outstanding of 4833541 and a Short% of Float of 4.79.
